Drug-Induced Alopecia: Review of the Literature

September 1995 in “ PubMed ”

M E Llau, R. Viraben, Jean‐Louis Montastruc

New to Valproic acid? There is a guide in the encyclopedia. Read the guide →

drug-induced alopecia antimitotic agents psychotropic drugs tricyclic antidepressants lithium anticonvulsants valproic acid beta-adrenoceptor antagonists anticoagulants antithyroid drugs oral contraceptives cimetidine retinoids amphetamines hair loss hair thinning baldness

Studysummary This review discusses the wide range of drugs potentially causing reversible or irreversible hair loss and emphasizes the difficulty of diagnosing drug-induced alopecia without withdrawal of the suspected medication; it reports no new clinical findings.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Related Research

9 / 9 results

research Childhood Alopecia Areata: An Overview of Treatment and Recent Patents

5 citations , July 2020 in “Recent patents on inflammation & allergy drug discovery”

This review discusses the genetics, therapy, and prognosis of childhood alopecia areata, noting that while current treatments are not curative, new modalities may improve future outcomes; it reports no new clinical results.

research The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review

1 citations , February 2019 in “PubMed”

This source reports that topical minoxidil effectively treats hair loss in androgenetic alopecia, varying efficacy by ethnic groups, and when combined with other therapies, shows increased effectiveness for conditions like alopecia areata and congenital hair disorders.

research Off-Label Use of Topical Minoxidil in Alopecia: A Review

32 citations , January 2019 in “American Journal of Clinical Dermatology”

This review discusses the use of topical minoxidil for various types of alopecia and reports mixed evidence on its efficacy, with stronger support noted for conditions like eyebrow hypotrichosis and chemotherapy-induced alopecia.

research Advanced Approaches in Alopecia

4 citations , June 2017 in “Pharmaceutical and Biological Evaluations”

This review examines current and emerging treatments for androgenetic alopecia and alopecia areata, noting no new results, and highlights promising approaches like novel drug combinations and gene therapy.

research Efficacy of Topical Latanoprost Versus Minoxidil and Betamethasone Valerate on the Treatment of Alopecia Areata

15 citations , May 2017 in “Journal of Dermatological Treatment”

In this study, patients with alopecia areata experienced significant hair regrowth using topical latanoprost, minoxidil, or betamethasone valerate, with the addition of latanoprost enhancing the effectiveness of betamethasone valerate, showcasing these treatments as safe and effective options.

research Treating Alopecia Areata: Current Practices Versus New Directions

26 citations , October 2016 in “American journal of clinical dermatology”

New treatments like JAK inhibitors show promise for reversing alopecia areata.

research Alopecia Areata: Evidence-Based Treatments

71 citations , March 2009 in “Seminars in cutaneous medicine and surgery”

This review discusses evidence for alopecia areata treatments, highlighting their ability to stimulate hair growth but noting limited data on long-term efficacy and impact on quality of life.

research Drug-Induced Hair Disorders

40 citations , August 2006 in “Current Drug Safety”

This article reviews how various drugs may cause hair loss, stimulate growth, or alter hair characteristics, but reports no new clinical results; drug-induced hair loss is typically reversible.

research The Treatment of Alopecia Areata

21 citations , September 1987 in “PubMed”

This article reviews various treatments for alopecia areata, noting the variable success in hair regrowth and the popularity of corticosteroids, but does not report new clinical results.